Annual Gross Margin
81.86%
-0.66%-0.80%
December 1, 2024
Summary
- As of March 10, 2025, XERS annual gross profit margin is 81.86%, with the most recent change of -0.66% (-0.80%) on December 1, 2024.
- During the last 3 years, XERS annual gross margin has risen by +8.72% (+11.92%).
- XERS annual gross margin is now -17.93% below its all-time high of 99.74%, reached on December 31, 2017.
Performance
XERS Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
84.23%
+9.28%+12.38%
December 31, 2024
Summary
- As of March 10, 2025, XERS quarterly gross profit margin is 84.23%, with the most recent change of +9.28% (+12.38%) on December 31, 2024.
- Over the past year, XERS quarterly gross margin has stayed the same.
- XERS quarterly gross margin is now -20.18% below its all-time high of 105.53%, reached on December 31, 2018.
Performance
XERS Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
XERS Gross Margin Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.8% | 0.0% |
3 y3 years | +11.9% | +1.4% |
5 y5 years | +99.1% | +1.4% |
XERS Gross Margin Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -0.8% | +11.9% | -1.3% | +17.7% |
5 y | 5-year | -0.8% | +99.1% | -1.3% | +1338.7% |
alltime | all time | -17.9% | +99.1% | -20.2% | +1338.7% |
Xeris Biopharma Holdings Gross Margin History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | 84.23%(+12.4%) |
Dec 2024 | 81.86%(-0.8%) | - |
Sep 2024 | - | 74.95%(-10.6%) |
Jun 2024 | - | 83.79%(-1.8%) |
Mar 2024 | - | 85.31%(+2.8%) |
Dec 2023 | 82.52%(+3.8%) | 82.95%(-0.1%) |
Sep 2023 | - | 83.03%(+3.6%) |
Jun 2023 | - | 80.12%(-4.6%) |
Mar 2023 | - | 83.98%(+3.7%) |
Dec 2022 | 79.47%(+8.7%) | 81.02%(-1.6%) |
Sep 2022 | - | 82.30%(+1.6%) |
Jun 2022 | - | 80.99%(+13.1%) |
Mar 2022 | - | 71.58%(-7.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | 73.14%(+34.6%) | 77.19%(+8.9%) |
Sep 2021 | - | 70.89%(+14.3%) |
Jun 2021 | - | 62.01%(-20.2%) |
Mar 2021 | - | 77.72%(+44.5%) |
Dec 2020 | 54.35%(+32.2%) | 53.77%(-23.1%) |
Sep 2020 | - | 69.89%(+94.6%) |
Jun 2020 | - | 35.92%(-628.2%) |
Mar 2020 | - | -6.80%(-148.6%) |
Dec 2019 | 41.11%(-58.8%) | 14.00%(-86.7%) |
Dec 2018 | - | 105.53%(+25.6%) |
Mar 2018 | - | 84.03%(-15.4%) |
Dec 2017 | 99.74%(+0.5%) | - |
Jun 2017 | - | 99.29% |
Dec 2016 | 99.26% | - |
FAQ
- What is Xeris Biopharma Holdings annual gross profit margin?
- What is the all time high annual gross margin for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual gross margin year-on-year change?
- What is Xeris Biopharma Holdings quarterly gross profit margin?
- What is the all time high quarterly gross margin for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly gross margin year-on-year change?
What is Xeris Biopharma Holdings annual gross profit margin?
The current annual gross margin of XERS is 81.86%
What is the all time high annual gross margin for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual gross profit margin is 99.74%
What is Xeris Biopharma Holdings annual gross margin year-on-year change?
Over the past year, XERS annual gross profit margin has changed by -0.66% (-0.80%)
What is Xeris Biopharma Holdings quarterly gross profit margin?
The current quarterly gross margin of XERS is 84.23%
What is the all time high quarterly gross margin for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly gross profit margin is 105.53%
What is Xeris Biopharma Holdings quarterly gross margin year-on-year change?
Over the past year, XERS quarterly gross profit margin has changed by 0.00% (0.00%)